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The fusion (F) protein of measles virus mediates membrane fusion. In this study, we investigated the
molecular basis of the cell–cell fusion activity of the F protein. The N465H substitution in the heptad
repeat B domain of the stalk region of the F protein eliminates this activity, but an additional muta-
tion in the DIII domain of the head region – N183D, F217L, P219S, I225T or G240R – restores cell–cell
fusion. Thermodynamically stabilized by the N465H substitution, the F protein required elevated
temperature as high as 40 C to promote cell–cell fusion, whereas all ﬁve DIII mutations caused
destabilization of the F protein allowing the highest fusion activity at 30 C. Stability complementa-
tion between the two domains conferred an efﬁcient cell–cell fusion activity on the F protein at
37 C.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction fusion, the F protein performs refolding from a thermodynamicallyMeasles virus (MV), a member of the genus Morbillivirus in the
family Paramyxoviridae, possesses two glycoprotein spikes, hemag-
glutinin (H) and fusion (F) proteins, on the surface of its envelope.
MV spreads its infection by binding of the H protein to the cellular
receptors followed by membrane fusion of virus envelope with the
target cell plasma membrane (envelope fusion) and/or of the
infected cell membrane with the neighboring uninfected cell mem-
brane (cell–cell fusion), releasing virus RNA genome into the cyto-
plasm [1]. The F protein is a homotrimer protein playing a principal
role in membrane fusion. After synthesized at rough ER as an inac-
tive precursor, F0, the F protein should be cleaved by furin in the
trans-Golgi into active complex of disulﬁde-linked F1 and F2 sub-
units on the way of the transport to the cell surface [2]. The fusion
peptide exposed anew at the N-terminus of the F1 subunit is
indispensable to exert fusion activity. To promote membranemetastable prefusion form to a highly stable postfusion form, on
the way of which it should get over an energetically activated
unstable intermediate state [3–6]. To overcome this energy barrier
at 37 C MV requires an activation signal from the H protein [7–
11]. Crystallization of the prefusion F protein of parainﬂuenzavirus
5 (PIV5), a paramyxovirus related to MV, has advanced the mech-
anistic understanding of the F protein refolding [12]. Upon activa-
tion by the hemagglutinin-neuraminidase protein (an attachment
protein corresponding to the H protein of MV), the heptad repeat
B (HR-B) domain in the stalk region of the F protein melts and
opens breaking its interaction with the head region accompanied
by unpacking of the fusion peptide as well as refolding of the DIII
domain of the head region, resulting in the assembly of the
coiled-coil short fragments into a long heptad repeat A (HR-A)
and translocation of the fusion peptide toward the target cell
membrane. The HR-A and HR-B helices of the transiently formed
unstable pre-hairpin intermediate are then combined into the sta-
ble six-helix bundle to complete the refolding, through which
merge of the lipid bilayers could be induced. The mechanisms of
signal transmission from the attachment protein and the core pro-
cesses of the F protein refolding are considered conserved among
paramyxoviruses [5,13–17]. Many amino acid substitutions that
alter the fusion activity of the F protein have been identiﬁed
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formations of these microdomains are essentially important for the
fusion activity.
Recently, we isolated a variant of a clinical MV lacking cell–cell
fusion activity with a single point substitution, N465H, in the HR-B
domain of the F protein. The variant easily generated revertant
viruses that demonstrate cell–cell fusion, and all the 5 such back
mutant viruses carried an additional amino acid substitution in
the DIII domain. In this study, we characterized the effect of each
amino acid substitution on the cell–cell fusion activity in relation
to the thermodynamic stability of the F protein molecule, and
show how these amino acid mutations in the HR-B and DIII
domains cooperatively modulate fusion activity of the F protein.
2. Materials and methods
2.1. Cells and viruses
Vero cells constitutively expressing human signaling lympho-
cyte activation molecule (Vero/hSLAM) (a gift from Y. Yanagi)
[26] and Vero cells were maintained in Dulbecco’s modiﬁed Eagle’s
medium (DMEM) supplemented with 7% fetal bovine serum (FBS).
A marmoset B-cell line cells transformed with Epstein–Barr virus
(B95a) were maintained in high-glucose DMEM supplemented
with 10% FBS and BHK cells constitutively expressing T7 RNA poly-
merase (BHK/T7-9) (a gift from N. Ito and M. Sugiyama) [27] were
maintained in RPMI 1640 medium supplemented with 8% FBS and
0.6 mg/ml hygromycin B.
The yuKE strain of MV (genotype H1) isolated from a measles
patient was passaged once in B95a cells followed by 10 times in
Vero/hSLAM cells. The cloned viruses were then obtained by pick-
ing either one of the syncytia (clone 1) or blindly the infected cells
without syncytium (clone 2). The recombinant MVs (rMVs) were
generated according to Seki et al. [28] as described previously
[29] using MV full-length genome plasmids. T7 RNA polymerase-
expressing vaccinia virus (vTF7-3) [30] was a gift from B. Moss.
2.2. Plasmid construction
cDNA of the F protein mRNA of the yuKE strain clone 1 was syn-
thesized by reverse transcription-PCR. The HpaI-PstI fragment (nt
6362–7867 according to the IC-B strain genome sequence, Gen-
Bank: AB016162) of the p(+)MV323c72-EGFP plasmid [29] derived
from the p(+)MV323-EGFP (a gift from Y. Yanagi) [31] was replaced
by the corresponding fragment of the clone 1, which generated the
full-length genome plasmids p(+)MV323c72-EGFP/F-WT(H1) car-
rying the wild-type (WT) F gene of the yuKE strain. Amino acid sub-
stitutions, N183D, F217L, P219S, I225T, G240R and N465H, were
introduced separately or in combination to the p(+)MV323c72-
EGFP/F-WT(H1) to obtain the full-length genome plasmids for
mutant rMVs.
For expression of proteins using plasmid, cDNA of the WT and
mutant F genes as well as the H gene of the yuKE strain were
cloned into pcDNA3 plasmid (Invitrogen Life Technologies). In
the series of F protein cleavage site mutant, the furin cleavage
motif RRHKR (amino acid 108–112) was changed to the trypsin
cleavage motif VPQSR of Sendai virus [32].
Precise primer sequences to construct these plasmids are avail-
able on request.
2.3. Quantitative cell–cell fusion assay
Vero cells seeded in 24-well plates were transfected with 0.5 lg
each of the F protein- and the H protein-expressing plasmids using
polyethyleneimine (Polysciences), infected with vTF7-3 at amultiplicity of infection (MOI) of 2 and incubated at 30 C or
37 C. At 24 h post-transfection, the cells were overlaid with
Vero/hSLAM cells and further incubated at 30 C for 18 h, or at
37 C or 40 C for 12 h in the presence of 100 lM cycloheximide.
The cells were ﬁxed, stained with crystal violet and numbers of
syncytia and nuclei per syncytium were counted under micro-
scope. Cell–cell fusion activity was shown as the product by multi-
plying the two values.
2.4. Cell surface biotinylation and Western blotting analysis
Vero cells in 24-well plates were transfected with 0.5 lg of the F
protein-expressing plasmid using Lipofectamine LTX (invitrogen),
infected with vTF7-3 at an MOI of 2 and incubated at 37 C or
30 C for 24 h. Then cells were incubated with 0.25 mg of EZ-Link
Sulfo-NHS-SS-Biotin (Thermo Scientiﬁc) at room temperature for
30 min followed by lysis (150 mM NaCl, 1.0% Triton X-100,
50 mM Tris-HCl, pH 8.0) at 4 C for 1 h. The lysate clariﬁed by cen-
trifugation was mixed with Streptavidin Sepharose High Perfor-
mance (GE Healthcare Bio-Science) at 4 C for 120 min. The
adsorbed biotinylated proteins were subjected to SDS–polyacryl-
amide gel electrophoresis and electroblotting onto PVDF mem-
branes (GE Healthcare Bio-Science). The F proteins were detected
using rabbit polyclonal antibody against MV F protein as the ﬁrst
antibody as described previously [29].
2.5. Structure modeling of the F protein
Homology-based structure model of prefusion MV F protein
was built using the X-ray structure of PIV5 F protein (PDB: 2B9B)
[12] with the Molecular Operating Environment software (Chemi-
cal Computing Group). The model structure was evaluated with the
3D proﬁle method [33] implemented in the Discovery Studio soft-
ware (Accelrys).3. Results
3.1. Defect of MV cell–cell fusion activity due to the F protein N465H
substitution was restored by an additional mutation in the DIII domain
From an MV clinical isolate yuKE strain, we plaque puriﬁed two
clones: the clone 1 forming large syncytia typical for MV and the
clone 2 lacking syncytium formation. The clone 1 possessed N465
(GenBank: AB968383) commonly observed in MV WT F proteins,
but H465 of the clone 2 was not found in databases. The rMV pos-
sessing either theWT or mutant F protein (F-WT or F-N465H) certi-
ﬁed that theN465H substitution is responsible for the defect of cell–
cell fusion activity of the clone 2 (Fig. 1A). The residue 465 is located
in the HR-B domain in the stalk region of the MV F protein (Fig. 1D,
see Fig. 5A).
The rMV with the mutant F-N465H protein generated revert-
ant viruses that form syncytia. Each of 5 such revertants pos-
sessed a single point mutation, N183D, F217L, P219S, I225T or
G240R in the DIII domatin in the head region of the F protein (DIII
mutations) besides the N465H substitution. rMVs carrying double
mutations in the F protein (F-N183D/N465H, F-F217L/N465H, F-
P219S/N465H, F-I225T/N465H and F-G240R/N465H) conﬁrmed
that these DIII mutations were responsible for restoration of
cell–cell fusion activity (Fig. 1B). rMVs with a single DIII mutation
in the F protein (F-N183D, F-P219S and F-G240R), however, could
not be recovered at all, and with F-F217L protein demonstrated
small syncytium (Fig. 1C), which suggested that the DIII muta-
tions do not simply enhance the cell–cell fusion activity of the
F protein.
Fig. 1. Cytopathic effect of the cells infected with rMVs. Vero/hSLAM cells were
overlaid with BHK/T7-9 cells transfected with a plasmid carrying the full genome of
an EGFP-expressing rMV together with support plasmids to initiate MV replication,
and incubated at 37 C for 72 h. After ﬁxation with 1% paraformaldehyde, EGFP
expression in the infected cells was observed under a ﬂuorescence microscope.
Magniﬁcation; 200. rMVs carrying (A) the F-WT or F-N465H protein, the F protein
(B) with N465H substitution and one of the DIII mutations, and (C) with one of the
DIII mutated F proteins. (D) Locations of the amino acid substitutions. A schematic
diagram of the MV F protein with the positions of amino acids whose substitutions
were identiﬁed in this study.
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is alleviated by the N465H substitution
Then, the F-N465H protein and the F proteins carrying DIII
mutations (DIII mutated F proteins) were expressed using plasmids
to characterize their cell–cell fusion activity. The F-N465H protein
did not show cell–cell fusion activity (Fig. 2A) although amount ofFig. 2. Effect of the N465H and the DIII mutations on fusion function of the F protein. (A) C
expressing one of the F proteins together with the H protein-expressing plasmid and
incubated further 12 h and stained with crystal violet. Numbers of syncytia and nuclei
demonstrated by multiplying these two parameters. Black column, F-WT or F-N465H pro
with N465H substitution and one of the DIII mutations. (B) Cell surface expression of
plasmids, incubated at 37 C for 24 h, and then biotinylated and lysed. Biotinylated cell
subjected to immunoblot analysis using rabbit polyclonal antibody against the F protein
Amounts of the mutant F proteins were demonstrated relative to that of the F-WT protcell surface F1 subunit was comparable with that of the F-WT pro-
tein (Fig. 2B). On the contrary, the F-N183D, F-P219S and F-G240R
proteins that hindered recovery of rMVs also demonstrated no
cell–cell fusion, which might be explained by the drastically
decreased F1 subunit expression (Fig. 2A). Fig. 2B indicates that
the DIII mutations interfere with the cleavage of the F protein by
furin into the fusion-active F1 subunit. Amounts of the F1 subunits
as well as the total F proteins (combined F0 and F1 proteins) rela-
tive to those of the F-WT protein on the cell surface (Fig. 2B) were
equivalent to those in the whole cell lysate (data not shown). The
transport efﬁciency, therefore, of the F proteins including the
cleaved forms must not be affected by the mutations. It should
be noted that the trace amounts of the F1 subunit support the rel-
atively high cell–cell fusion activity of the F-F217L and F-I225T
proteins, which might be explained by the enhanced speciﬁc fusion
activities (activity per the amount of F1 subunit) of these F proteins
at 37 C (see Fig. 4E). The N465H substitution could alleviate the
restricted cleavage of the DIII mutated F proteins, and restored
cell–cell fusion activity of the F-N183D/N465H, F-P219S/N465H
and F-G240R/N465H proteins. The observation coincides with the
cell–cell fusion activities of the rMVs in Fig. 1.
3.3. The N183D, P219S and G240R mutations prevent the F protein
from holding the proper conformation at 37 C, which is relieved by
the N465H substitution
Since the DIII mutations were considered to affect the F protein
conformation resulting in furin resistance, the F proteins were
expressed at 30 C to see if they hold proper conformation at lower
temperature. As shown in Fig. 3C, the DIII mutated F proteins were
more readily cleaved by furin at 30 C, and accordingly, the F-
N183D, F-P219S and F-G240R proteins restored cell–cell fusion
activity (Fig. 3A). These 3 F proteins, however, did not show cell–
cell fusion activity at 37 C (Fig. 3B), which indicates that the 3 F
proteins once synthesized correctly at 30 C should be unstable
and easily lose the proper conformation to exert cell–cell fusion
at 37 C. On the other hand, the F-P217L and F-I225T proteins
expressed at 30 C demonstrated cell–cell fusion activity at 37 C
suggesting that they maintain correct conformation at 37 C.ell–cell fusion activities of the F proteins. Vero cells were transfected with a plasmid
incubated at 37 C for 24 h. Then the cells were overlaid with Vero/hSLAM cells,
in each syncytium were counted under microscope, and cell–cell fusion activity is
tein; white column, DIII mutated F proteins; gray column, doubly mutated F proteins
the F proteins at 37 C. Vero cells were transfected with the F protein-expressing
surface proteins were precipitated with streptavidin-coated sepharose beads, and
. Combined amount of F0 and cleaved F1 proteins was shown as the total F protein.
ein.
Fig. 3. Effect of the lowered temperature on fusion function of the F proteins. (A and B) Cell–cell fusion activities of the F proteins synthesized at 30 C. Vero cells were
transfected with a plasmid expressing one of the F proteins together with the H protein-expressing plasmid and incubated at 30 C for 24 h. Then the cells were overlaid with
Vero/hSLAM cells and incubated (A) at 30 C further 18 h or (B) at 37 C for 12 h in the presence of 100 lM cycloheximide. Cell–cell fusion activity was quantiﬁed as described
in Fig. 2A. Black column, F-WT or F-N465H protein; white column, DIII mutated F proteins; gray column, doubly mutated F proteins with N465H substitution and one of the
DIII mutations. (C) Cell surface expression of the F proteins at 30 C. Vero cells were transfected with the F protein-expressing plasmids, incubated at 30 C, biotinylated at
24 h posttransfection, and lysed. Biotinylated cell surface proteins were analyzed by immunoblotting as described in Fig. 2B.
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inducing furin resistance, each F protein molecule varies in stabil-
ity at 37 C. In contrast, the F-N465H protein demonstrated no
cell–cell fusion activity at 30 C regardless of its proper conforma-
tion to be cleaved. Defect of the F-N465H protein in cell–cell fusion
activity at 37 C might not be caused by instability of the protein.
The eliminated cell–cell fusion activity of the F-N183D, F-P219S
and F-G240R proteins at 37 C was restored when N465H substitu-
tion was additionally introduced (F-N183D/N465H, F-P219S/
N465H and F-G240R/N465H proteins), which suggests that
N465H substitution should play a role to support the F protein
structure in proper conformation.
3.4. Cell–cell fusion activities of the F-N465H protein and the DIII
mutated F proteins are reciprocally temperature dependent
To compare accurate temperature dependence of the cell–cell
fusion activity between the F-N465H and the DIII mutated F pro-
teins, the cleavage site of each F protein was changed to that of
Sendai virus so as to be cleaved by supplemented trypsin but not
spontaneously by cellular furin [32]. When the F proteins with
the cleavage site mutation are expressed at 30 C and cleaved by
trypsin before temperature shift, the system enabled us to exclude
the inﬂuence of the F proteins synthesized de novo because such F
proteins would not be cleaved into the fusion-active form.
As shown in Fig. 4A–C, cell–cell fusion activity of the F-WT pro-
tein was enhanced as the temperature increased, and the F-N465H
protein exhibited the activity only when temperature was as high
as 40 C. These two F proteins required higher temperature to
perform refoldingmore efﬁciently. Contrarily, cell–cell fusion activ-
ities of all the DIII mutated F proteins decreased as the temperature
increased. The F-N183D, F-P219S and F-G240R proteins lost the
activity at 37 C, and the F-P217L and F-I225T proteins showed
some restricted activity at 37 C but not at 40 C. The results
demonstrate that the proper conformation of these DIII mutated F
proteins once constructed at 30 C was lost at higher temperatures.
On the other hand, signiﬁcantly high speciﬁc fusion activities(activity per the amount of F1 subunit in Fig. 4D) of all the DIII
mutated F proteins at 30 C and of the F-P217L and F-I225T proteins
at 37 C suggest that the DIII mutated F proteins more readily
induce membrane fusion than the F-WT protein at low tempera-
tures (Fig. 4E). The F proteins carrying one of the DIII mutations
and N465H substitution demonstrated cell–cell fusion activity at
any temperature with the highest value at 37 C.
3.5. Residues 183, 219 and 240 are located in the interface of the F
protein trimer
On the model structure of the MV F prefusion form constructed
using the crystal structure of the PIV5 F protein, residues 183, 219
and 240 are located in the inter-subunit interface of the F protein
trimer and in close proximity of amino acids of the neighboring
subunit chains (Fig. 5B). These amino acids should be involved in
the mutual interaction of the subunits. On the other hand, residues
217 and 225 are almost buried in a subunit and are surrounded by
hydrophobic residues (Fig. 5C).
4. Discussion
The membrane fusion process of paramyxovirus is driven by a
drastic conformational change of the F protein from a metastable
prefusion to a highly stable postfusion form, on the way of which
the molecule should get over a thermodynamically activated
unstable intermediate state [3–6]. To overcome this energy barrier,
MV F protein requires an activation signal from the H protein at
37 C [7–11]. Heat treatment at 60 C, however, has been shown
to serve as a surrogate for the H-mediated F activation [11], which
implys that the raised temperature decreases the conformational
stability of the F prefusion form lowering the energy barrier to
the postfusion form. The same effect would explain the enhanced
cell–cell fusion activity of the F-WT protein at higher temperatures
shown in Fig. 4A–C.
Most of the mutations in the HR-B domain reported up to now
stimulate cell–cell fusion activity [22–24]. N462K, one of such
Fig. 4. Temperature dependence of the fusion function of the F proteins. (A–C) Cell–cell fusion activities of the F proteins evaluated using cleavage site mutated F proteins.
Vero cells were transfected with a plasmid expressing one of the F proteins together with the H protein-expressing plasmid and incubated at 30 C. At 24 h posttransfection,
the culture medium was replaced with the medium including 1 lg/ml trypsin and incubated 37 C for 1 h. Then the cells were overlaid with Vero/hSLAM cells and (A)
continuously incubated at 30 C for 18 h, or transferred to (B) 37 C or (C) 40 C and incubated for 12 h in the presence of 100 lM cycloheximide and trypsin inhibitor. At 18 h
or 12 h post cocultivation, cell–cell fusion activity was evaluated as described in Fig. 2A. Black column, F-WT or F-N465H protein; white column, DIII mutated F proteins; gray
column, doubly mutated F proteins with N465H substitution and one of the DIII mutations. (D) Cell surface expression of the cleavage site mutated F proteins at 30 C. Vero
cells were transfected with a plasmid expressing cleavage site mutated F protein and incubated at 30 C. At 24 h posttransfection, the culture medium was replaced with the
medium including 1 lg/ml trypsin and incubated 37 C for 1 h. Then the cell surface proteins were biotinylated and analyzed by immunoblotting as described in Fig. 2B. (E)
Speciﬁc cell–cell fusion activity of the F proteins. Speciﬁc cell–cell fusion activities were calculated by dividing cell–cell fusion activity at each temperature (A–C) by the
amount of cleaved F1 subunit (D).
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associating the HR-B/HR-B-linker domains with the head region in
the F prefusion form [13]. Contrarily, N465H should somehow
increase the conformational stability of the F prefusion form, since
it inhibited the fusion activity at 37 C but 40 C (Fig. 4A–C). The
bulky ring of H465 might protect the triple-helix bundle of the
HR-B domain from water-mediated dissociation.
On the other hand, cell–cell fusion activity of the DIII mutated F
proteins decreased as temperature increased (Fig. 4A–C). Reactivity
to the monoclonal antibody recognizing the F postfusion form
[11,15] suggested spontaneous refolding of these DIII mutants to
the postfusion form at the high temperature (data not shown),
an useless event for the membrane fusion. At lower temperatures,however, they exhibited extremely high speciﬁc fusion activities
(Fig. 4E). Therefore, each DIII mutation would be considered as a
destabilization factor lowering the energy barrier to the postfusion
form, which enhances the fusion process unless too high tempera-
ture further lowers the energy barrier too much, inducing the
wasteful spontaneous refolding.
Destabilization mechanisms of the DIII mutations might not be
equal. One group of the mutations (N183D, G240R, P219S) has a
destabilization effect to lose the fusion activity due to the sponta-
neous refolding at lower temperature than the other group (F217L
and I225T) (Fig. 4A–C). In a homology-modeled structure of the MV
F prefusion form, the former mutations are located in the inter-
subunit interface, whereas, the positions of the latter are buried
Fig. 5. Mutation sites mapped in a model structure of MV F prefusion form. (A) Overall view. Shown are the main chains in ribbon representation colored by subunit,
mutation sites in sphere representation colored by atom, and the cleavage sites (CS) as white spheres. N465 is located in the stalk region near the interface between the head
and stalk regions. The other mutation sites studied are in the head region. (B) Close-up view of the mutation sites in the head region. In addition to the same representation
elements as in A, Connolly surface of each subunit is semi-transparently shown. N183, G240 and P219 are located in the inter-subunit interface, whereas F217 and I225 are
almost completely buried in a subunit. Residues in inter-subunit contact with N183, G240 and P219 are shown in stick representation colored by atom. They are L197 for
N183; L204, R208 and T211 for G240; and E201, M337 and P338 for P219. (C) Close-up view of F217 and I225. Basically, the same representation is employed as in B. The
fusion peptide region (F-pep) is shown in ribbon representation of a dark shade of blue. The stick representation is used for showing hydrophobic residues surrounding F271
and I225 (namely, V83, L84, I87, A90, L91, M94, L123, L137, I213, L216, P224, I269, V272 and I279), and also showing related residues (T270, V280, S144 and I147). Among the
residues in F-pep (L123, L137, S144 and I147), L123 and L137 are in contact with I225; S144 and I147 are in contact with residues (T270 and V280, respectively) in such a
beta-sheet that also contain residues (I269 and I279) in contact with F217.
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Mutations N180D, G240R and P219S alter the physicochemical
properties, such as charge, size and polarity, of the side chains
located in the inter-subunit, which could be a cause to destabilize
the inter-subunit interaction (Fig. 5B). On the other hand, mutation
I225T breaks the hydrophobic interaction between I225 and a part
of the fusion peptide region (L123 and L137), and mutation F217L
possibly affects the positioning of the beta-sheet which is in con-
tact with both F217 on one side and another part of the fusion pep-
tide region (S144 and I147) on the other side, weakening the
interaction between the beta-sheet and fusion peptide (Fig. 5C).
Thus, these mutations could make the fusion peptide region more
easily dissociate from the head region.
Doyle et al. has demonstrated [21] that residues 462 in the HR-B
and 94 in the DIII domains are involved jointly in conformational
destabilization that links suppressed cell–cell fusion activity. In
our present study, by the addition of the N465H substitution in
the HR-B, the DIII mutated F proteins restored cell–cell fusion
activity at 37 C, which indicates that, even if the HR-B and DIII
domains are distant from each other in the prefusion form, a stabil-
ization effect caused by H465 somehow compensates a destabiliza-
tion effect caused by each of the DIII mutations to exert cell–cell
fusion activity at 37 C.
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